Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
Butwick
A J
AJ
Department of Anesthesiology, Stanford University School of Medicine, Stanford, California 94305, USA. ajbut@stanford.edu
Carvalho
B
B
D000773:Anesthesia, Obstetrical / Q000379:methods*; D000775:Anesthesia, Spinal / Q000379:methods*; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000627:therapeutic use; D001241:Aspirin / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077144:Clopidogrel; D005260:Female; D005343:Fibrinolytic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077425:Fondaparinux; D017408:Guidelines as Topic; D046748:Hematoma, Epidural, Spinal / Q000139:chemically induced / Q000517:prevention & control*; D006493:Heparin / Q000493:pharmacokinetics / Q000627:therapeutic use; D006629:Hirudins / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D011134:Polysaccharides / Q000493:pharmacokinetics / Q000627:therapeutic use; D011247:Pregnancy; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D014859:Warfarin / Q000493:pharmacokinetics / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006629:Hirudins; D011134:Polysaccharides; D014859:Warfarin; D006493:Heparin; D000077144:Clopidogrel; D000077425:Fondaparinux; D013988:Ticlopidine; D001241:Aspirin